Back

L-PGDS/ PGD2 is a regulator of cardiac metabolism during aging?

19 May 2025 (14:00 - 14:45)
Organised by: Logo
Congress Presentation Part of: Pathophysiology and treatment Cardiac Biology and Physiology HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Lesia Savchenko

Institute of Cardiovascular and Metabolic Diseases, Toulouse (France)

6 More presentations in this session

Presentation thumbnail
Inflamed atrial tissues of patients with atrial fibrillation are characterized by pro-oxidant and pro-remodeling responses: synergistic inhibition by an SGLT2 inhibitor plus a GLP-1R activation
Doctor W. Fakih (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Mural cell dysfunction contributes to diastolic heart failure by promoting endothelial dysfunction and vessel remodeling
Professor E. Jones (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Circulating low-grade inflammation in human pulmonary arterial hypertension promotes eNOS-NO/ROS imbalance: Involvement of the angiotensin and the endothelin pathways and prevention by EPA:DHA 6:1
Ms H. MUZAMMEL (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Reversal of age-related diastolic dysfunction by micronized purified flavonoid fraction in rats with attenuation of low-grade inflammation, eNOS-NO/ROS imbalance, and left ventricular fibrosis
Professor V. Schini-Kerth (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Effect of SGLT2i on myocardial remodeling due to cardiorenal syndrome in rat model of heart failure
Doctor M. Sykora (Bratislava, SK)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology and treatment

The Event

Event poster

Heart Failure 2025

19 May 2025 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Do myocardial substrates affect cardiac function in disease?
thumbnail
Congress Session
Metabolic reprogramming and crosstalk in cardiometabolic and vascular disease
thumbnail
Congress Session
Molecular mechanisms of cardiovascular ageing: from senescence to regeneration

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources